{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:35:16Z","timestamp":1715589316949},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,30]]},"DOI":"10.7759\/cureus.8930","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:06:51Z","timestamp":1593544011000},"source":"Crossref","is-referenced-by-count":3,"title":["Why We Fail at Heart Failure: Lymphatic Insufficiency Is Disregarded"],"prefix":"10.7759","author":[{"given":"Philip","family":"Houck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari","family":"Dandapantula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Hardegree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet M","family":"Massey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8776","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy CW","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013, 128:240-327. 10.1161\/CIR.0b013e31829e8776","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000136815.73623.BE","article-title":"Right ventricular myocardium derives from the anterior heart field","volume":"95","author":"Zaffran S","year":"2004","unstructured":"Zaffran S, Kelly RG, Meilhac SM, Buckingham ME, Brown NA. Right ventricular myocardium derives from the anterior heart field. Circ Res. 2004, 95:261-268. 10.1161\/01.RES.0000136815.73623.BE","journal-title":"Circ Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.13172\/2053-0781-1-1-511","article-title":"Evolution of heart failure: crotchety old cardiologist","volume":"1","author":"Houck PD","year":"2013","unstructured":"Houck PD. Evolution of heart failure: crotchety old cardiologist. OA Med Hypothesis. 2013, 1:7. 10.13172\/2053-0781-1-1-511","journal-title":"OA Med Hypothesis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0033-0620(98)80049-2","article-title":"Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function","volume":"40","author":"Santamore WP","year":"1998","unstructured":"Santamore WP, Dell'Italia LJ. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis. 1998, 40:289-308. 10.1016\/s0033-0620(98)80049-2","journal-title":"Prog Cardiovasc Dis"},{"key":"ref5","article-title":"Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study","volume":"31","author":"Marshall NS","year":"2008","unstructured":"Marshall NS, Wong KKH, Liu PY, Cullen SRJ, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008, 31:1079-1085.","journal-title":"Sleep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506459","article-title":"Adaptive servo-ventilation for central sleep apnea in systolic heart failure","volume":"373","author":"Cowie RM","year":"2015","unstructured":"Cowie RM, Woehrle H, Wegscheider K, et al.. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015, 373:1095-1105. 10.1056\/NEJMoa1506459","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.09.014","article-title":"Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF Registry","volume":"4","author":"Arzt M","year":"2016","unstructured":"Arzt M, Woehrle H, Oldenburg O, et al.. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF Registry. JACC Heart Fail. 2016, 4:116-125. 10.1016\/j.jchf.2015.09.014","journal-title":"JACC Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi890","article-title":"Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study-using propensity score methods","volume":"27","author":"Ahmed A","year":"2006","unstructured":"Ahmed A, Husain A, Love TE, et al.. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study-using propensity score methods. Eur Heart J. 2006, 27:1431-1439. 10.1093\/eurheartj\/ehi890","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2013.11.004","article-title":"Continuous ultrafiltration for congestive heart failure: the CUORE trial","volume":"20","author":"Marenzi G","year":"2014","unstructured":"Marenzi G, Muratori M, Cosentino ER, et al.. Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail. 2014, 20:9-17. 10.1016\/j.cardfail.2013.11.004","journal-title":"J Card Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo MR","year":"2007","unstructured":"Costanzo MR, Guglin ME, Saltzberg MT, et al.. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007, 49:675-683. 10.1016\/j.jacc.2006.07.073","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral Tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam MA","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, et al.. Effects of oral Tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007, 297:1319-1331. 10.1001\/jama.297.12.1319","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham WT","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, et al.. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005, 46:57-64. 10.1016\/j.jacc.2005.03.051","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor AL","year":"2004","unstructured":"Taylor AL, Ziesche S, Yancy C, et al.. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004, 351:2049-2057. 10.1056\/NEJMoa042934","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.05.160","article-title":"Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systematic review","volume":"196","author":"Farag M","year":"2015","unstructured":"Farag M, Mabote T, Shoaib A, Zhang J, Nabhan AF, Clark AL, Cleland JG. Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systematic review. Int J Cardiol. 2015, 196:61-69. 10.1016\/j.ijcard.2015.05.160","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.01.027","article-title":"Potential impact of optimal implementation of evidence-based heart failure therapies on mortality","volume":"161","author":"Fonarow GC","year":"2011","unstructured":"Fonarow GC, Yancy CW, Hernandez AF, et al.. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J. 2011, 161:1024-1030. 10.1016\/j.ahj.2011.01.027","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray JJ","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, et al.. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014, 371:993-1004. 10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2008.03.006","article-title":"Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation","volume":"45","author":"Sossalla S","year":"2008","unstructured":"Sossalla S, Wagner S, Rasenack EC, et al.. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol. 2008, 45:32-43. 10.1016\/j.yjmcc.2008.03.006","journal-title":"J Mol Cell Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt B","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999, 341:709-717. 10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"The Digitalis Investigation Group","year":"1997","unstructured":"The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997, 336:525-553. 10.1056\/NEJM199702203360801","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.04.007","article-title":"Acute decompensated heart failure: the shrinking role of inotropic therapy","volume":"46","author":"Dec GW","year":"2005","unstructured":"Dec GW. Acute decompensated heart failure: the shrinking role of inotropic therapy. J Am Coll Cardiol. 2005, 46:65-67. 10.1016\/j.jacc.2005.04.007","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland JG","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E, Nick Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005, 352:1539-1549. 10.1056\/NEJMoa050496","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH Trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results","volume":"1","author":"Carson P","year":"2013","unstructured":"Carson P, Wertheimer J, Miller A, et al.. The STICH Trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. JACC Heart Fail. 2013, 1:400-408. 10.1016\/j.jchf.2013.04.012","journal-title":"JACC Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.072256","article-title":"Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial","volume":"125","author":"Deja MA","year":"2012","unstructured":"Deja MA, Grayburn PA, Sun B, et al.. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation. 2012, 125:2639-2648. 10.1161\/CIRCULATIONAHA.111.072256","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/78.3.361","article-title":"Calorie restriction and aging: review of the literature and implications for studies in humans","volume":"78","author":"Heilbronn LK","year":"2003","unstructured":"Heilbronn LK, Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr. 2003, 78:361-369. 10.1093\/ajcn\/78.3.361","journal-title":"Am J Clin Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister FA","year":"2004","unstructured":"McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004, 109:1004-1009. 10.1161\/01.CIR.0000116764.53225.A9","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00297-6","article-title":"Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials","volume":"32","author":"Dries DL","year":"1998","unstructured":"Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol. 1998, 32:695-703. 10.1016\/s0735-1097(98)00297-6","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.12.3198","article-title":"Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators","volume":"94","author":"Doval HC","year":"1996","unstructured":"Doval HC, Nul DR, Grancelli HO, et al.. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation. 1996, 94:3198-3203. 10.1161\/01.cir.94.12.3198","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm262","article-title":"Influence of left bundle branch block on long-term mortality in a population with heart failure","volume":"28","author":"Tabrizi F","year":"2007","unstructured":"Tabrizi F, Englund A, Rosenqvist R, Wallentin L, Stenestrand U. Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J. 2007, 28:2449-2455. 10.1093\/eurheartj\/ehm262","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients: a systematic review and meta-analysis","volume":"52","author":"Groenveld HF","year":"2008","unstructured":"Groenveld HF, Januzzi JL, Danman K, Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. JACC. 2008, 52:818-827. 10.1016\/j.jacc.2008.04.061","journal-title":"JACC"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.10.011","article-title":"Effect of influenza on outcomes in patients with heart failure","volume":"7","author":"Panhwar MS","year":"2019","unstructured":"Panhwar MS, Kalra A, Gupta T, et al.. Effect of influenza on outcomes in patients with heart failure. JACC Heart Fail. 2019, 7:112-117. 10.1016\/j.jchf.2018.10.011","journal-title":"JACC Heart Fail"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.12.017","article-title":"Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure","volume":"141","author":"Zairis MN","year":"2010","unstructured":"Zairis MN, Tsiaousis GZ, Georgilas AT, et al.. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol. 2010, 141:284-290. 10.1016\/j.ijcard.2008.12.017","journal-title":"Int J Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(15)61043-9","article-title":"Is mode presentation affecting the mortality of patients presenting with acute heart failure?","volume":"65","author":"Shoaib A","year":"2015","unstructured":"Shoaib A, John J, Wong K, Cleland J, Clark A. Is mode presentation affecting the mortality of patients presenting with acute heart failure?. J Am Coll Cardiol. 2015, 65:A1043. 10.1016\/S0735-1097(15)61043-9","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq194","article-title":"Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction","volume":"13","author":"Thune JJ","year":"2011","unstructured":"Thune JJ, Signorovitch JE, Kober L, et al.. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. Eur J Heart Fail. 2011, 13:148-153. 10.1093\/eurjhf\/hfq194","journal-title":"Eur J Heart Fail"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.13.1759","article-title":"Ischemic mitral regurgitation long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigionin F","year":"2001","unstructured":"Grigionin F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001, 103:1759-1764. 10.1161\/01.cir.103.13.1759","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:20:2","article-title":"Heart failure in patients with diabetes mellitus","volume":"3","author":"Rosano GM","year":"2017","unstructured":"Rosano GM, Vitale C, Seferovic P. Heart failure in patients with diabetes mellitus. Card Fail Rev. 2017, 3:52-55. 10.15420\/cfr.2016:20:2","journal-title":"Card Fail Rev"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.13172\/2053-0781-1-1-510","article-title":"Alternative view of congestive heart failure exacerbations: role of lymphatic function and inflammation","volume":"1","author":"Houck PD","year":"2013","unstructured":"Houck PD. Alternative view of congestive heart failure exacerbations: role of lymphatic function and inflammation. OA Med Hypothesis. 2013, 1:6.","journal-title":"OA Med Hypothesis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008661","article-title":"Impact of type 2 myocardial infarction (MI) on hospital\u2010level MI outcomes: implications for quality and public reporting","volume":"7","author":"Sameer A","year":"2018","unstructured":"Sameer A, Strassle PD, Qamar A, et al.. Impact of type 2 myocardial infarction (MI) on hospital\u2010level MI outcomes: implications for quality and public reporting. J Am Heart Assoc. 2018, 7:008661. 10.1161\/JAHA.118.008661","journal-title":"J Am Heart Assoc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2018.1435121","article-title":"The trouble with troponin","volume":"31","author":"Michel JB","year":"2018","unstructured":"Michel JB, Schussler JM. The trouble with troponin. Proc (Bayl Univ Med Cent). 2018, 31:238-239. 10.1080\/08998280.2018.1435121","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0626fje","article-title":"Molecular and functional analyses of the contractile apparatus in lymphatic muscle","volume":"17","author":"Muthuchamy M","year":"2003","unstructured":"Muthuchamy M, Gashev A, Boswell N, Dawson N, Zawieja D. Molecular and functional analyses of the contractile apparatus in lymphatic muscle. Faseb J. 2003, 17:920-922. 10.1096\/fj.02-0626fje","journal-title":"Faseb J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1113\/JP272088","article-title":"Lymphatic pumping: mechanics, mechanisms and malfunction","volume":"69","author":"Scallan JP","year":"2016","unstructured":"Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ. Lymphatic pumping: mechanics, mechanisms and malfunction. J Physiol. 2016, 69:5749-5768. 10.1113\/JP272088","journal-title":"J Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34710-why-we-fail-at-heart-failure-lymphatic-insufficiency-is-disregarded","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:27Z","timestamp":1707506307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34710-why-we-fail-at-heart-failure-lymphatic-insufficiency-is-disregarded"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.8930","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,30]]}}}